SLC5A2 and type 2 diabetes mellitus: Tang et al. [138] conducted a meta-analysis to assess the effect of SGLT2 inhibitors on electrolyte levels in patients with T2DM, including 18 randomized controlled trials, and observed a significant increase in serum Mg in patients treated with SGLT2 inhibitors as compared with placebo.